Cargando…

Increasing Radiation Dose to the Thoracic Marrow Is Associated With Acute Hematologic Toxicities in Patients Receiving Chemoradiation for Esophageal Cancer

Purpose: To test the hypothesis that increasing radiation dose to the thoracic marrow (TM) contributes to the development of hematologic toxicities (HT) in esophageal cancer (EC) patients receiving chemoradiation therapy (CRT). Methods: We identified EC cases treated with curative intent CRT at our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabian, Denise, Ayan, Ahmet, DiCostanzo, Dominic, Barney, Christian L., Aljabban, Jihad, Diaz, Dayssy A., Miller, Eric D., Wuthrick, Evan, Williams, Terence M., Bazan, Jose G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429979/ https://www.ncbi.nlm.nih.gov/pubmed/30931257 http://dx.doi.org/10.3389/fonc.2019.00147

Ejemplares similares

A novel methodology for the optimization of transmission and dosimetric leaf gap parameters
por: DiCostanzo, Dominic J., et al.
Publicado: (2022)

The role of bone marrow and spleen irradiation in the development of acute hematologic toxicity during chemoradiation for esophageal cancer
por: Chin, Alexander L., et al.
Publicado: (2018)

Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma
por: Sebastian, Nikhil T., et al.
Publicado: (2019)

Predictors of Acute Hematologic Toxicity in Women Receiving Extended-Field Chemoradiation for Cervical Cancer: Do Known Pelvic Radiation Bone Marrow Constraints Apply?
por: Hara, Jared H.L., et al.
Publicado: (2022)

Analysis of Radiation Dose to the Shoulder by Treatment Technique and Correlation With Patient Reported Outcomes in Patients Receiving Regional Nodal Irradiation
por: Bazan, Jose G., et al.
Publicado: (2021)

The lifetime of a linac monitor unit ion chamber
por: Cetnar, Ashley J., et al.
Publicado: (2021)

Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation
por: Kumar, T, et al.
Publicado: (2019)

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
por: Shi, Feiya, et al.
Publicado: (2022)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
por: Warren, Samantha, et al.
Publicado: (2017)

From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis
por: Aljabban, Jihad, et al.
Publicado: (2020)

Nutritional Status in Patients with Esophageal Cancer Receiving Chemoradiation and Assessing the Efficacy of Usual Care for Nutritional Managements
por: Movahed, Sara, et al.
Publicado: (2020)

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2020)

Bilateral video-assisted thoracic surgery for esophageal cancer with left inferior pulmonary vein invasion following chemoradiation therapy
por: Fujii, Masakazu, et al.
Publicado: (2023)

Dietary Flaxseed in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation
por: Berman, Abigail T, et al.
Publicado: (2013)

Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer
por: Das, Rishi, et al.
Publicado: (2023)

Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
por: Shukla, Nikhil A, et al.
Publicado: (2020)

Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation
por: Sims, Travis T., et al.
Publicado: (2021)

FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation
por: McDonald, Jordan, et al.
Publicado: (2021)

Stage I Squamous Cell Carcinoma of the Anus: Is Radiation Therapy Alone Sufficient Treatment?
por: Miller, Eric, et al.
Publicado: (2020)

Efficacy of chemical shift MRI for differentiating diffuse red bone marrow reconversion and hematological malignancies
por: AKMAN, Burcu, et al.
Publicado: (2019)

Bone Marrow Senescence and the Microenvironment of Hematological Malignancies
por: Hellmich, Charlotte, et al.
Publicado: (2020)

Blinding of Residency Applications in Medical Physics: Promises and Pitfalls
por: Cetnar, Ashley J., et al.
Publicado: (2023)

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
por: David, John M., et al.
Publicado: (2019)

NCCC308: Nutrition and Management of Feedlot Cattle to Optimize Performance, Carcass Value, and Environmental Compatibility – Feature Collection - Nutrition and Management of Finishing Cattle
por: Swanson, Kendall C, et al.
Publicado: (2023)

Association of financial assistance programs and time to completion of therapy in women receiving chemoradiation for cervical cancer
por: Gillen, Jessica M., et al.
Publicado: (2020)

HO‐1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy
por: Akaishi, Ryujiro, et al.
Publicado: (2021)

Bone Marrow Biopsy. Hematology in the Light of Sternal Puncture
por: Clement, David H.
Publicado: (1949)

Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies
por: Wobus, Manja, et al.
Publicado: (2023)

Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma
por: Steins, Anne, et al.
Publicado: (2019)

Analysis of bone marrow supernatant neutrophil gelatinase‐associated lipocalin and hematological parameters in hematological malignancy
por: Cho, Chi‐Hyun, et al.
Publicado: (2020)

Quantification of tongue mobility impairment using optical tracking in patients after receiving primary surgery or chemoradiation
por: Kappert, K. D. R., et al.
Publicado: (2019)

Survival prediction models for patients with anal carcinoma receiving definitive chemoradiation: A population-based study
por: Wu, Yinhang, et al.
Publicado: (2020)

Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
por: Zhu, Shan, et al.
Publicado: (2016)

Apparent diffusion coefficient values detected by diffusion-weighted imaging in the prognosis of patients with locally advanced esophageal squamous cell carcinoma receiving chemoradiation
por: Liu, Shu, et al.
Publicado: (2016)

Assessment of Food Safety Knowledge and Behaviors of Cancer Patients Receiving Treatment
por: Paden, Holly, et al.
Publicado: (2019)

Local and Systemic Pathogenesis and Consequences of Regimen-Induced Inflammatory Responses in Patients with Head and Neck Cancer Receiving Chemoradiation
por: Russi, Elvio G., et al.
Publicado: (2014)

Congenital ichthyosis patient with squamous cell carcinoma of the skin who received concurrent chemoradiation: A case report
por: Cerra-Franco, Alberto, et al.
Publicado: (2017)

Utility of bone marrow examination in retinoblastoma and their correlation with hematological features
por: Yadav, Geeta, et al.
Publicado: (2023)

Achalasia Combined with Esophageal Cancer Treated by Concurrent Chemoradiation Therapy
por: Park, Jun Chul, et al.
Publicado: (2009)

Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients
por: Warnecke-Eberz, Ute, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mc5f1taebtcc57gcf7t2n3o2dj